This study focuses on adults with Immune Thrombocytopenia (ITP), a condition where the immune system attacks blood platelets, leading to bleeding problems. The research compares two different treatment approaches for patients experiencing mild to severe bleeding symptoms. The purpose is to determine if one treatment method works as effectively as the other.
The first treatment combination consists of intravenous immunoglobulin given through a vein along with oral prednisone tablets taken daily for three weeks. The second treatment option involves high-dose dexamethasone tablets taken for four days. Both treatments aim to increase the number of platelets in the blood and reduce bleeding symptoms.
The study will track how quickly patients respond to treatment over the first five days, particularly looking at improvements in platelet counts and reduction in bleeding. Patients will be monitored for six months to evaluate the long-term effectiveness of both treatments. Throughout the study, doctors will regularly check platelet counts and assess any bleeding symptoms.
France 
